NRXP · NRX Pharmaceuticals, Inc.
$3.27
-0.07 (-2.10%)
At close · Aug 14
Earnings today
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As such, the Company has concluded that substantial doubt exists regarding the Company's ability to continue as a going concern for a period of at least twelve months from the date of issuance of these consolidated financial statements.”View the 10-Q filed Aug 14, 2026
Market Cap
$141.58M
Shares
43.30M
Weekly off-exchange (dark pool / OTC) trading volume reported to FINRA under its OTC/ATS Transparency data. ATS volume is executed on alternating trading systems (dark pools); non-ATS OTC is other over-the-counter dealer volume. The off-exchange share is total off-exchange volume as a percentage of consolidated weekly trading volume for the same Monday–Friday week.
Off-Exchange Volume History
| Week Start | ATS Volume | Non-ATS OTC Volume | Total Off-Exchange | % of FINRA Weekly Volume |
|---|---|---|---|---|
| 2026-07-06 | 420,398 | 1,527,716 | 1,948,114 | 45.7% |
| 2026-06-29 | 316,122 | 1,067,731 | 1,383,853 | 45.2% |
| 2026-06-22 | 758,743 | 2,327,403 | 3,086,146 | 49.4% |
| 2026-06-15 | 303,658 | 1,028,647 | 1,332,305 | 44.6% |
| 2026-06-08 | 575,639 | 2,376,473 | 2,952,112 | 45.5% |
| 2026-06-01 | 1,220,651 | 3,786,473 | 5,007,124 | 42.0% |
| 2026-05-25 | 614,744 | 4,506,819 | 5,121,563 | 56.4% |
| 2026-05-18 | 435,892 | 2,608,671 | 3,044,563 | 51.7% |
| 2026-05-11 | 607,215 | 2,918,784 | 3,525,999 | 53.5% |
| 2026-05-04 | 614,512 | 2,119,397 | 2,733,909 | 50.4% |
| 2026-04-27 | 399,088 | 1,725,039 | 2,124,127 | 52.9% |
| 2026-04-20 | 728,196 | 4,313,370 | 5,041,566 | 52.4% |
| 2026-04-13 | 407,880 | 2,466,517 | 2,874,397 | 53.4% |
| 2026-04-06 | 293,615 | 1,338,891 | 1,632,506 | 55.0% |
| 2026-03-30 | 223,048 | 745,766 | 968,814 | 51.9% |
| 2026-03-23 | 623,952 | 3,166,695 | 3,790,647 | 55.7% |
| 2026-03-16 | 442,737 | 2,084,371 | 2,527,108 | 49.9% |
| 2026-03-09 | 433,657 | 995,389 | 1,429,046 | 55.4% |
| 2026-03-02 | 347,031 | 1,178,357 | 1,525,388 | 53.5% |
| 2026-02-23 | 441,194 | 1,428,975 | 1,870,169 | 58.4% |
| 2026-02-16 | 368,227 | 921,617 | 1,289,844 | 54.8% |
| 2026-02-09 | 178,545 | 718,824 | 897,369 | 52.2% |
| 2026-02-02 | 287,613 | 1,753,030 | 2,040,643 | 61.1% |
| 2026-01-26 | 369,005 | 1,573,826 | 1,942,831 | 61.1% |
| 2026-01-19 | 335,679 | 1,295,856 | 1,631,535 | 59.7% |
| 2026-01-12 | 790,919 | 11,947,455 | 12,738,374 | 48.6% |
| 2026-01-05 | 283,253 | 1,644,432 | 1,927,685 | 59.2% |
| 2025-12-29 | 270,085 | 808,580 | 1,078,665 | 51.6% |
| 2025-12-22 | 210,637 | 951,511 | 1,162,148 | 64.0% |
| 2025-12-15 | 270,855 | 1,612,183 | 1,883,038 | 53.6% |
| 2025-12-08 | 348,444 | 1,116,330 | 1,464,774 | 58.3% |
| 2025-12-01 | 265,765 | 1,167,519 | 1,433,284 | 58.8% |
| 2025-11-24 | 135,742 | 398,914 | 534,656 | 59.6% |
| 2025-11-17 | 423,678 | 1,475,332 | 1,899,010 | 62.6% |
| 2025-11-10 | 393,105 | 720,744 | 1,113,849 | 57.6% |
| 2025-11-03 | 390,470 | 1,029,808 | 1,420,278 | 54.9% |
| 2025-10-27 | 397,258 | 1,073,817 | 1,471,075 | 55.9% |
| 2025-10-20 | 254,852 | 676,451 | 931,303 | 58.2% |
| 2025-10-13 | 215,912 | 1,004,257 | 1,220,169 | 50.7% |
| 2025-10-06 | 364,686 | 1,138,956 | 1,503,642 | 56.0% |
| 2025-09-29 | 252,211 | 967,582 | 1,219,793 | 58.1% |
| 2025-09-22 | 144,078 | 984,099 | 1,128,177 | 59.6% |
| 2025-09-15 | 167,787 | 851,125 | 1,018,912 | 51.3% |
| 2025-09-08 | 319,783 | 1,631,391 | 1,951,174 | 61.1% |
| 2025-09-01 | 80,022 | 754,131 | 834,153 | 61.0% |
| 2025-08-25 | 515,203 | 1,126,285 | 1,641,488 | 55.5% |
| 2025-08-18 | 507,589 | 1,165,562 | 1,673,151 | 65.0% |
Showing 1–47 of 47 weeks
Key facts
CIK
1719406
CUSIP
629444209
13F (30d)
47 filings
47 filers
Visit website
Investor relations